Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism before and after treatment

Experimental and Clinical Endocrinology and Diabetes

Volumn 115, Issue 8, 2007, Pages 522-526

  Baskol, G ^a   Atmaca, H ^a   Tanriverdi, F ^a   Baskol, M ^a   Kocer, D ^a   Bayram, F ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Hypothyroidism; Lipid peroxidation; Malondialdehyde; Paraoxonase

Indexed keywords

ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE; MALONALDEHYDE; NITRIC OXIDE; SUPEROXIDE DISMUTASE; THYROID HORMONE; THYROXINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HYPOTHYROIDISM; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; SPECTROPHOTOMETRY; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; FEMALE; HASHIMOTO DISEASE; HUMANS; HYPOTHYROIDISM; MALE; MALONDIALDEHYDE; MIDDLE AGED; NITRIC OXIDE; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; THYROXINE; TRIIODOTHYRONINE;

EID: 35848964067     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-981457     Document Type: Article

References (40)

1. Halliwell B. Free radicals, antioxidants and human disease: curiosity, cause or consequence? Lancet 1994; 344: 721-724
2. Paller MS. Hypothyroidism protects against free radical damage in ischemic acute renal failure. Kidney Int 1986; 29: 1162-1166
3. Dumitriu L, Bartoc R, Ursu H et al. Significance of high levels of serum malonyl dialdehyde (MDA) and ceruloplasmin (CP) in hyper- and hypothyroidism. Endocrinologie 1988; 26: 35-38
4. Costantini F, Pierdomenico SD, Cesare D De, Remigis P De, Bucciarelli T, Bittolo Bon G, Cazzolato G, Nubile G, Guanano MT, Sensi S, Cuccurullo F, Mezzetti A. Effect of thyroid function on LDL oxidation. Arterioscler Thromb Vasc Biol 1998; 18: 732-737
5. Pereira B, Rosa LF, Safi DA et al. Control of superoxide dismutase, catalase and glutathione peroxidase activities in rat lymphoid organs by thyroid hormones. J Endocrinol 1994; 140: 73-77
6. Swaroop A, Ramasarma T. Heat exposure and hypothyroid conditions decrease hydrogen peroxide generation in liver mitocondria. Biochem J 1985; 226: 403-408
7. Sundaram V, Hanna AN, Koneru L et al. Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation. J Clin Endocrinol Metab 1997; 82: 3421-3424
8. Gutteridge JM. Free radicals in disease processes: a compilation of cause and consequence. Free Radic Res Commun 1993; 19: 141-158
9. -), superoxide dismutases, and related matters. J Biol Chem 1997; 272: 18515-18518
10. Berlett BS, Stadtman ER. Protein oxidation in aging, disease and oxidative stress. J Biol Chem 1997; 272: 20313-20316
11. Gambhir JK, Lali P, Jain AK. Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis. Clin Biochem 1997; 30: 351-355
12. Draper HH, Hadley M. A review of recent studies on the metabolism of exogenous and endogenous malondialdehyde. Xenobiotica 1990; 20: 901-907
13. Romero FJ, Morell B, Romero MJ, Jareno EJ, Romero B, Marin N, Roma J. Lipid peroxidation products and antioxidants in human disease. Environmental Health Perspectives 1998; 106: 1229-1234
14. Aviram M, Rosenblat M, Bisgaier CL et al. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its function: A possible peroxidative role for paraoxonase. J Clin Invest 1998; 101: 1581-1590
15. Gan KN, Smolen A, Eckerson HW et al. Purification of human serum paraoxonase/arylesterase: evidence for one esterase catalyzing both activities. Drug Metab Dispos 1991; 19: 100-106
16. Rozenberg O, Rosenblat M, Coleman R et al. Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice. Free Rad Biol Med 2003; 34: 774-784
17. Ayub A, Mackness MI, Arrol S et al. Serum paraoxonase after myocardial infarction. Arterioscler Thromb Vasc Biol 1999; 19: 330-335
18. Mackness MI, Harty D, Bhatnagar D et al. Serum paraoxonase activity in familial hypercholesterolaemia and insulin dependent diabetes mellitus. Atherosclerosis 1991; 86: 193-199
19. Stichtenoth DO, Frölich JC. Nitric oxide and inflammatory joint disease. Br J Rhumatol 1998; 37: 246-257
20. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial cell injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-1624
21. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol 1996; 271: 3424-3437
22. Jain SK. Evidence for membrane lipid peroxidation during the invivo aging of human erythrocytes. Biochem Biophys Acta 1988; 937: 205-210
23. Eckerson EW, Romson J, Wyte C et al. The human serum paraoxonase polymorphism: Identification of phenotypes by their response to salts. Am J Hum Genet 1983; 35: 214-227
24. Sun Y, Oberley LW, Li YA. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497-500
25. Bories PN, Bories C. Nitrate determination in biological fluids by an enzymatic one-step assay with nitrate reductase. Clin Chem 1995; 41: 904-907
26. Halliwell B, Chirico S. Lipid peroxidation: its mechanism, measurement and significance. Am J Clin Nutr 1993; 57: 715-724
27. Halliwell B. Reactive oxygen species in living system: source, biochemistry, and role in human disease. Am J Med 1991; 91: 14S-22S
28. Azizi F, Raiszadeh F, Solati M et al. Serum paraoxonase 1 activity is decreased in thyroid dysfunction. J Endocrinol Invest 2003; 26: 703-709
29. Sarandol E, Tas S, Dirican M et al. Oxidative stress and serum paraoxonase activity in experimental hypothyroidism: effect of vitamin E supplementation. Cell Biochem Funct 2005; 23: 1-8
30. Aviram M, Rosenblat M, Billecke S, Erogul J, Sorenson R, Bisgaier CL, Newton RS, La Du B. Human serum paraoxonase (PON1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic Biol Med 1999; 26: 892-904
31. Baskol G, Demir H, Baskol M, Kilic E, Ates F, Kocer D, Muhtaroglu S. Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis. Clinical Biochemistry 2005; 38: 951-955
32. Baskol G, Karakucuk S, Oner AO, Baskol M, Kocer D, Mirza E, Saraymen R, Ustdal M. Serum paraoxonase 1 activity and lipid peroxidation levels in patients with age related macular degeneration. Ophthalmologica 2006; 220: 12-16
33. Baskol G, Baskol M, Yurci A, Ozbakir O et al. Serum paraoxonase 1 activity and malondialdehyde levels in patients with ulcerative colitis. Cell Biochem Funct 2006; 24: 283-286
34. Baskol M, Baskol G, Deniz K et al. A new marker for lipid peroxidation: serum paraoxonase activity in non-alcoholic steatohepatitis. Turk J Gastroenterol 2005; 16: 119-123
35. Karakucuk S, Baskol G, Oner A et al. Serum paraoxonase activity is decreased in the active stage of Behcet's disease. Br J Ophthalmol 2004; 88: 1256-1258
36. Kumon Y, Nakauchi Y, Suehiro T, Shiinoki T, Tanimoto N, Inoue M, Nakamura T, Hashimoto K, Sipe JD. Proinflammatory cytokines but not acute phase serum amyloid A or C-reactive protein, down regulate paraoxonase 1 (PON1) expression by Hep G2. Amyloid 2002; 9: 160-164
37. Weetman AP. Cellular immune responses in autoimmune thyroid disease. Clin Endocrinol (Oxf) 2004; 61: 405-413
38. Van Lenten BJ, Wagner AC, Nayak DP et al. High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection. Circulation 2001; 103: 2283-2288
39. Feingold KR, Memon RA, Moser AH et al. Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response. Atherosclerosis 1998; 139: 307-315
40. Evereklioglu C, Türköz Y, Er H et al. Increased nitric oxide production in patients with Behcet's disease: Is it a new activity marker? J Am Acad Dermatol 2002; 46: 50-54